SMS Pharmaceuticals Ltd
SMSPHARMASMS Pharmaceuticals Ltd
SMSPHARMAPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
46.99 | 5.08 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
46.01 | 6.09 | 0.55% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
SMS Pharmaceuticals Limited is engaged in manufacturing and sale of bulk drugs and active pharmaceutical ingredients (APIs), and their intermediates.
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Zydus Lifesciences Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 615.01 | 439.58 | 465.07 | 468.31 | 417.06 | 566.62 | 525.07 | 526.94 | 713.72 | 713.71 | ||||||||||
Raw Materials | 399.45 | 325.03 | 294.32 | 307.19 | 259.50 | 313.27 | 387.95 | 299.73 | 592.64 | 592.64 | ||||||||||
Power & Fuel Cost | 33.81 | 18.23 | 22.57 | 21.75 | 18.99 | 23.31 | 32.58 | 36.73 | ||||||||||||
Employee Cost | 38.11 | 26.92 | 32.80 | 35.59 | 39.35 | 41.17 | 51.02 | 55.04 | ||||||||||||
Selling & Administrative Expenses | 25.23 | 10.23 | 9.67 | 9.84 | 10.18 | 19.02 | 21.12 | 16.62 | ||||||||||||
Operating & Other expenses | 25.59 | -17.42 | 9.97 | 0.40 | 3.90 | 45.27 | -87.41 | 59.36 | ||||||||||||
EBITDA | 92.82 | 76.59 | 95.74 | 93.54 | 85.14 | 124.58 | 119.81 | 59.46 | 121.08 | 121.07 | ||||||||||
Depreciation/Amortization | 19.43 | 19.18 | 19.90 | 19.27 | 22.07 | 22.28 | 32.15 | 32.13 | 31.52 | 31.52 | ||||||||||
PBIT | 73.39 | 57.41 | 75.84 | 74.27 | 63.07 | 102.30 | 87.66 | 27.33 | 89.56 | 89.55 | ||||||||||
Interest & Other Items | 17.11 | 15.82 | 15.48 | 11.92 | 12.32 | 11.19 | 19.16 | 21.98 | 23.46 | 23.45 | ||||||||||
PBT | 56.28 | 41.59 | 60.36 | 62.35 | 50.75 | 91.11 | 68.50 | 5.35 | 66.10 | 66.10 | ||||||||||
Taxes & Other Items | 15.38 | 13.09 | 28.59 | 22.31 | 19.18 | 28.60 | 6.28 | 12.41 | 16.28 | 16.28 | ||||||||||
Net Income | 40.90 | 28.50 | 31.77 | 40.04 | 31.57 | 62.51 | 62.22 | -7.06 | 49.82 | 49.82 | ||||||||||
EPS | 4.83 | 3.37 | 3.75 | 4.73 | 3.73 | 7.38 | 7.35 | -0.83 | 5.89 | 5.89 | ||||||||||
DPS | 0.20 | 0.20 | 0.25 | 0.25 | 0.25 | 0.30 | 0.30 | 0.30 | 0.00 | 0.30 | ||||||||||
Payout ratio | 0.04 | 0.06 | 0.07 | 0.05 | 0.07 | 0.04 | 0.04 | — | 0.00 | 0.05 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
SMS Pharmaceuticals Ltd | 46.99 | 5.08 | — |
Sun Pharmaceutical Industries Ltd | 41.74 | 5.96 | 0.81% |
Zydus Lifesciences Ltd | 31.44 | 5.49 | 0.25% |
Cipla Ltd | 29.39 | 5.11 | 0.87% |
Price Comparison
Compare SMSPHARMA with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 2 Mutual Funds holding SMS Pharmaceuticals Ltd
Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Quant Momentum Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.0360% | Percentage of the fund’s portfolio invested in the stock 1.26% | Change in the portfolio weight of the stock over the last 3 months -0.15% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 50/67 (-9) |
Quant Healthcare Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.5744% | Percentage of the fund’s portfolio invested in the stock 4.44% | Change in the portfolio weight of the stock over the last 3 months 0.39% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 14/33 (-5) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 22, 2023
Dividend/Share
₹0.30
Ex DateEx Date
Sep 22, 2023
Cash Dividend
Ex DateEx DateSep 22, 2022
Dividend/Share
₹0.30
Ex DateEx Date
Sep 22, 2022
Cash Dividend
Ex DateEx DateSep 22, 2021
Dividend/Share
₹0.30
Ex DateEx Date
Sep 22, 2021
Cash Dividend
Ex DateEx DateMar 26, 2020
Dividend/Share
₹0.25
Ex DateEx Date
Mar 26, 2020
Cash Dividend
Ex DateEx DateSep 19, 2019
Dividend/Share
₹0.25
Ex DateEx Date
Sep 19, 2019
Chemcon Speciality Chemicals Ltd leads losers in ‘B’ group
Selan Explorations Technology Ltd leads gainers in ‘B’ group
SMS Pharmaceuticals share price zooms after bagging licence to manufacture, supply oral COVID vaccines
SMS Pharma soars after receiving license to manufacture COVID-19 medicine
19 Indian companies get licence to make Pfizer’s oral generic
Taking Stock | Geopolitical tension roils market, indices see biggest single-day fall in nearly two years
SMS Pharmaceuticals consolidated net profit rises 109.94% in the September 2021 quarter
SMS Pharmaceuticals standalone net profit rises 152.17% in the June 2021 quarter
SMS Pharmaceuticals consolidated net profit rises 262.13% in the March 2021 quarter
SMS Pharmaceuticals standalone net profit rises 255.36% in the March 2021 quarter
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 8.79%, vs industry avg of 8.96%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.21% to 0.19%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 4.47%, vs industry avg of 15.15%